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Presynaptic muscarinic receptors labeled with [3H]dexetimide and noradrenaline in dog splenic nerves 
accumulated proximally to a ligature at the same rate of axonai transport. After fractionation by 
differenti~ centrifugation, specific [3H]quinuclidinyl benzilate or [3H]dexetim~de binding revealed a 
distribution profile similar to that of dopamine-&hydroxylase and noradrenaline. Subfractionation by 
density gradient centrifugation showed two peaks of muscarinic receptors; the peak of density 1.17 
contained noradrenaline and dopamine-/3-hydroxylase whereas that of density 1.14 was devoid of 
noradrenaline. Therefore the foregoing experiments provide evidence that presynaptic muscarinic 
receptors are transported in sympathetic nerves in synaptic vesicles which are similar to those containing 
noradrenaline and dopamine-~-hydroxylase. This suggests a possible coexistence of receptor and 
neurotransmitter in the same vesicle. 
Mkscarinic receptor Axonal transport 
I. INTRODUCTION 
In sympathetic nerves, axoplasmic flow is 
responsible for the transport of noradrenaline and 
dopamine-~-hydroxylase from the cell body to the 
nerve terminals [1,2]. Noradrenaline release from 
nerve endings is controlled by various regulatory 
mechanisms which imply, namely, the occurrence 
of presynaptic muscarinic receptors: the stimula- 
tion by acetylcholine of these receptor sites elicits 
an inhibitory effect on noradrenaline release ]3,4]. 
More direct evidence for this regulatory 
mechanism was provided when muscarinic recep- 
tors were found to accumulate on both sides of a 
ligature in dog splenic nerves, thus demonstrating 
a bidirectional axonal flow for these receptors 
[5,6]. Similar results were then obtained in cat 
hypogastric nerve [7] and in rat sciatic nerve [8]. 
We now report on the axoplasmic transport and 
the subcellular localization of muscarinic receptors 
from dog splenic nerves. 
Dopamine-P-hydroxyiase Synaptic vesicle 
2. MATERIALS AND METHODS 
Mongrel dogs were anesthesized with pentobar- 
bital (30 mglkg iv.) and the splenic nerve fibers 
were dissected near the bifurcation of the splenic 
artery. A silk thread ligature was tied around the 
splenic nerve. At different times after the opera- 
tion, l-cm segments proximal to the ligature were 
removed; from control animals, the whole nerve 
was dissected. After removing connective tissue, 
the splenic nerves were cut in small pieces and then 
homogenized in 30 vols of 0.25 M sucrose with a 
Dual1 homogenizer. The total homogenate so ob- 
tained was used as such. 
2.1, Differential and density gradient 
ce~trif~gatjo~ 
The total homogenate was submitted to dif- 
ferential centrifugation to give 5 pellets and a final 
supernatant as in [9]; Pi fraction at 6596 x gay for 
8 min; PZ and P3 at 20203 x g, for 15 and 30 min, 
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respectively; P.+ and PS at 55364 x gav for 22 and 
35 min, respectively. The pellets were suspended in 
2 vols of distilled water and used immediately for 
binding assays or stored at - 20°C for enzyme and 
protein measurement. 
For density gradient experiments, a particulate 
fraction was prepared as follows: after having cen- 
trifuged total homogenate at low speed (5000 rpm, 
10 min), the obtained pellet was resuspended in 
30 vols of 0.25 M sucrose and again homogenized 
and centrifuged. Both supernatants were pooled, 
filtered through one layer of surgical gauze and 
centrifuged at 30~ rpm for 30 min in a Ti65 
Rotor of a Spinco centrifuge. The pellet was 
suspended in l-2 vols of 0.25 M sucrose; 4 ml was 
layered on a 36-ml continuous gradient of sucrose 
(0.4-2 M) and allowed to equilibrate at 2’C in a 
vertical VT1 rotor (Spinco centrifuge) for 1 h at 
30000 rpm. Then 16 fractions of 2.5 ml were col- 
lected and 1.5 ml was diluted with distilled water 
for immediate use in binding assays, the remainder 
being stored at -20°C. 
2.2. Birding assays and marker enzymes 
Binding on muscarinic receptors was carried out 
using either f3H]dexetimide (spec. act. 
17 Ci/mmol; I.R.E., Fleurus, Belgium) or 
[3H]quinuclidinyl benzilate ([3H]QNB) (spec. act. 
31 Ci/mmol; NEN, Boston). Binding was per- 
formed with 0.1 nM [3H]dexetimide and 0.5 nM 
[3H]QNB in 5 ml of 50 mM phosphate buffer (pH 
7.4) and the rapid filtration technique was used as 
in [IO]. Before use, the filters were washed with 
1% BSA to reduce non-specific binding. Specific 
binding was the difference between total binding 
and binding in the presence of 2 x lo-’ M dex- 
etimide (blank). 
Dopamine-fi-hydroxylase was assayed as in Ill]. 
Marker enzymes and protein were measured as in 
[ 121. Noradrenaline was measured according to 
I131. 
3. RESULTS 
At different times after ligation, r3H]dexetimide 
binding and noradrenaline were determined in 
l-cm segments of dog splenic nerves above the 
ligature. Previous studies have shown that the 
[3H]dexetimide binding sites in these sympathetic 
nerves are of muscarinic nature [6]. Fig.1 shows 
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Fig. 1. Time course of the accumulation of stereospecific 
[3H]dexetimide binding and noradrenaline in l-cm 
segments of dog splenic nerves above (proximal to) a 
ligature. Each point represents he mean value obtained 
from 5 or 6 animals (+ SE). 
that both noradrenaline and muscarinic receptors 
increased linearly as a function of time. In- 
terestingly, the accumulation in the proximal part 
of the nerves was the same for both constituents. 
In contrast, the accumulation was not detectable 
when [jH]levetimide, the pharmacologically inac- 
tive enantiomer of dexetimide, was used as ligand 
161. 
To determine the intracellular localization of 
muscarinic receptors in sympathetic nerves, 
various fractions of dog splenic nerves were 
prepared by differential centrifugation. 
Muscarinic receptors were measured in vitro in all 
the fractions using either ~3HJdexetimide or 
13H]QNB as ligand and their distribution profiles 
were compared to those of marker enzymes and of 
noradrenaline. Fig.2 shows the distribution pattern 
of muscarinic receptors after differential cen- 
trifugation; specific [3H]dexetimide and [3H]QNB 
binding were found mainly enriched in the P3-PS 
fractions. The recovery, a little higher than 100070, 
was probably due to the presence in the total 
homogenate of substances inhibiting the binding. 
Interestingly, the distribution profiles of 
dopamine-~-hydroxylase, noradrenaline and 
5 ’ -nucleotidase were very similar to that of 
[‘HIQNB and ~3H]dexetimide binding. In contrast, 
cytochrome oxidase and N-acetylglucosaminidase 
revealed a quite different profile; they were mainly 
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recovered in the first fractions, the highest relative 
specific activity being in the PZ fraction. Note that 
a large amount (73%) of the lysosomal enzyme ap- 
peared in the supernatant, thus in a non- 
sedimentable form, which suggests that lysosomes 
had undergone much damage during the 
homogenization. In contrast, noradrenaline- 
containing vesicles appeared to be much less af- 
fected by this treatment. 
Subfractionation of muscarinic receptors from 
dog splenic nerves was carried out by submitting a 
particulate fraction, which involves the Pz-PS 
fractions, to equilibration in sucrose density gra- 
BINDING 
n:5 
dients. Because of the high non-specific binding of 
[3H]dexetimide in sucrose solutions, [3H]QNB was 
6- preferred for labelling muscarinic receptors. Fig.3 
57 
shows that in isopycnic centrifugation, [3H]QNB 
binding revealed two peaks; the first one 
L- equilibrated in zones of high density (peak 1.17); 
3- this peak corresponds to the distribution profile of 
2- noradrenaline and partly of the dopamine-,&- 
l- 
hydroxylase. The second peak of [3H]QNB binding 
O- 
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Fig.2. Distribution patterns of [3H]QNB and 
[3H]dexetimide binding, noradrenaline and marker 
enzymes in subcellular f actions of dog splenic nerves. 
The results are presented graphically in histograms 
following (141. The ordinate represents the relative 
specific activity (RSA), i.e., the percentage of activity in 
a given fraction against the percentage of protein 
recovered in this fraction. The results are means of 
different determinations (n) (+ SE). Recovery of 
[3H]dexetimide and [3H]QNB binding, noradrenaline 
and 5’-nucleotidase was 122, 108, 102 and 92’70, 
lb5 l-l0 Ii5 Ii0 
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Fig.3. Distribution of [3H]QNB binding, dopamine-fl- 
hydroxylase, noradrenaline, cytochrome oxidase and 
5 ’ -nucleotidase after isopycnic centrifugation of a 
particulate fraction from dog splenic nerves in a sucrose 
gradient. All recoveries ranged between 92 and 100%. 
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Fig.4. Model illustrating the bidirectional axonal 
transport in sympathetic nerves of muscarinic receptors 
which are or are not associated with noradrenaline in
synaptic vesicles (SV). N, nucleus; M, mitochondrion; 
ER, endoplasmic reticulum; GA, Golgi apparatus; LY, 
lysosome. 
was found in areas of lower density (peak 1.14); 
here only dopamine-,&hydroxylase was present but 
the amount of enzyme was less than in the peak 
1.17. 5 ’ -Nucleotidase was recovered in lower 
sucrose concentrations (1.13). 
4. DISCUSSION 
The foregoing results indicate that presynaptic 
muscarinic receptors in dog splenic nerves are 
transported in synaptic vesicles like noradrenaline 
and dopamine-,&hydroxylase. Sympathetic nerves 
are known to contain muscarinic receptors [5-81; 
the recent observation that muscarinic receptors 
from rat spleens markedly decreased following 
chemical sympathectomy with 6-hydroxydopamine 
supports this view [ 151. Similar results were recent- 
ly obtained in our laboratory (in preparation). 
In sympathetic nerves, fast axonal flow was 
reported for noradrenaline and dopamine-,& 
hydroxylase [1,2,16] and more recently for 
muscarinic receptors [5,6]. All the other enzymes 
so far measured from mitochondria, lysosomes, 
plasma membrane or cytosol were found to move 
at a much slower rate than the synaptic vesicles 
[ 17,181. Both muscarinic receptors and 
noradrenaline accumulated above a ligature on the 
splenic nerves at the same rate which was estimated 
to be 1.2 mm/h, a value which is in good agree- 
ment with previous values reported for dopamine- 
,&-hydroxylase and noradrenaline [ 1,2,16]. This 
suggests that both could be located within the same 
organelle. 
Fractionation experiments provided more direct 
evidence for close association of muscarinic recep- 
tors with synaptic vesicles. First after differential 
centrifugation, the muscarinic receptors labelled 
either with [3H]QNB or [3H]dexetimide were 
recovered in particles sedimenting at relatively high 
speed together with dopamine-P-hydroxylase, 
noradrenaline and 5 ‘-nucleotidase. In contrast, 
mitochondrial and lysosomal enzymes revealed a 
completely different pattern, which rules out a 
mitochondrial or lysosomal localization for the 
receptors. 
Sucrose density gradients revealed two peaks 
(density 1.17 and 1.14) which exactly corresponded 
to those of dopamine-,&hydroxylase and to that of 
noradrenaline. 5 ’ -Nucleotidase was found to 
equilibrate in a region of lower density and did not 
accumulate rapidly on both sides of a ligature (not 
shown) thus confirming that marker enzymes of 
plasma membranes are not associated with vesicles 
containing noradrenaline and dopamine+ 
hydroxylase [9,18-201. Consequently, muscarinic 
receptors in dog splenic nerves seem to be 
associated with dense vesicles (1.17) containing 
noradrenaline and dopamine-fl-hydroxylase and 
with less dense (1.14) vesicles devoid of 
noradrenaline but containing dopamine-fl- 
hydroxylase. Two peaks of dopamine-fl- 
hydroxylase have been found previously [9,20,21], 
peak 1.17 being always more pronounced than 
peak 1.14. The fact that less muscarinic receptors 
were found in peak 1.17 could be due to the 
presence of noradrenaline which might inhibit the 
binding; the IGO of noradrenaline in [3H]dex- 
etimide binding was 20 mM, a concentration 
which is relatively high but not incompatible with 
the high content of noradrenaline in the synaptic 
vesicles [22]. 
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From our results a model can be proposed 
(fig.4). Synaptic vesicles containing noradrenaline, 
dopamine-fl-hydroxylase and muscarinic receptors 
(presumably the ‘dense-core vesicles’) are syn- 
thesized and assembled in the cell body of sym- 
pathetic nerves and flow down towards the nerve 
terminals. There, noradrenaline and a part of 
dopamine-,&hydroxylase are released by exocytosis 
[19,21,22] and the receptors are externalized, thus 
becoming functional. After internalization or en- 
docytosis, the receptors together with membrane- 
bound dopamine-&hydroxylase could return to 
the cell body where they are either recycled or 
degraded. A recycling phenomenon directly in the 
nerve terminals cannot be excluded. Such a model 
implies that acetylcholine could play a role as a 
signal raising the internalization of muscarinic 
receptors in the nerve terminals [23]. 
Our experiments uggest he possible coexistence 
of a receptor and a neurotransmitter in the same 
organelle. It is too early to decide whether such an 
association is the rule in neurotransmission. 
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